Literature DB >> 29422007

K+ Channels of Müller Glial Cells in Retinal Disorders.

Feng Gao1, Lin-Jie Xu1, Yuan Zhao1, Xing-Huai Sun1, Zhongfeng Wang1.   

Abstract

BACKGROUND &
OBJECTIVE: Müller cell is the major type of glial cell in the vertebrate retina. Müller cells express various types of K+ channels, such as inwardly rectifying K+ (Kir) channels, big conductance Ca2+-activated K+ (BKCa) channels, delayed rectifier K+ channels (KDR), and transient A-type K+ channels. These K+ channels play important roles in maintaining physiological functions of Müller cells. Under some retinal pathological conditions, the changed expression and functions of K+ channels may contribute to retinal pathogenesis.
CONCLUSION: In this article, we reviewed the physiological properties of K+ channels in retinal Müller cells and the functional changes of these channels in retinal disorders. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  A-type K+ channels; BKCa channels; KDR; Kir channels; Müller cells; retinal disorders.

Mesh:

Substances:

Year:  2018        PMID: 29422007     DOI: 10.2174/1871527317666180202114233

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  2 in total

1.  Association between Serum Potassium with Risk of Onset and Visual Field Progression in Patients with Primary Angle Close Glaucoma: A Cross-Sectional and Prospective Cohort Study.

Authors:  Yichao Qiu; Jiaojiao Wei; Jian Yu; Yingzhu Li; Mingxi Shao; Jun Ren; Wenjun Cao; Shengjie Li; Xinghuai Sun
Journal:  Oxid Med Cell Longev       Date:  2022-06-23       Impact factor: 7.310

2.  Inhibiting the activation of MAPK (ERK1/2) in stressed Müller cells prevents photoreceptor degeneration.

Authors:  Shaoxue Zeng; Ting Zhang; Yingying Chen; Joshua Chu-Tan; Kaiyu Jin; So-Ra Lee; Michelle X Yam; Michele C Madigan; Nilisha Fernando; Adrian Cioanca; Fanfan Zhou; Meidong Zhu; Junjun Zhang; Riccardo Natoli; Xiaohui Fan; Ling Zhu; Mark C Gillies
Journal:  Theranostics       Date:  2022-09-11       Impact factor: 11.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.